| Literature DB >> 31606083 |
Monica Kruk1, Naomi Widstrom1, Sampreeti Jena1, Nicole L Wolter1, John F Blankenhorn1, Ibrahim Abdalla1, Tzu-Yi Yang1, Laurie L Parker2.
Abstract
Tyrosine kinases are important for many cellular processes and disruption of their regulation is a factor in diseases like cancer, therefore they are a major target of anticancer drugs. There are many ways to measure tyrosine kinase activity in cells by monitoring endogenous substrate phosphorylation, or by using peptide substrates and incubating them with cell lysates containing active kinases. However, most of these strategies rely on antibodies and/or are limited in how accurately they model the intracellular environment. In cases in which activity needs to be measured in cells, but endogenous substrates are not known and/or suitable phosphospecific antibodies are not available, cell-deliverable peptide substrates can be an alternative and can provide information on activation and inhibition of kinases in intact, live cells. In this chapter, we review this methodology and provide a protocol for measuring Abl kinase activity in human cells using enzyme-linked immunosorbent assay (ELISA) with a generic antiphosphotyrosine antibody for detection.Entities:
Keywords: Abl kinase; Cell penetrating peptide; K562 cells; Kinase substrate; Tyrosine kinase assay
Mesh:
Substances:
Year: 2019 PMID: 31606083 DOI: 10.1016/bs.mie.2019.06.026
Source DB: PubMed Journal: Methods Enzymol ISSN: 0076-6879 Impact factor: 1.600